
Poly Medicure’s Evaluation Revised Amidst Market Challenges and Valuation Concerns
2025-11-27 10:06:18Poly Medicure, a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a period marked by subdued financial trends and valuation pressures, impacting investor sentiment and stock performance.
Read More
Poly Medicure Hits Intraday High with Strong Trading Momentum
2025-11-24 10:32:13Poly Medicure recorded a robust intraday surge on 24 Nov 2025, touching a high of ₹2,011.8, reflecting a 7.26% rise during the trading session. This performance outpaced its sector and broader market indices, signalling notable trading activity in the healthcare services stock.
Read MoreWhy is Poly Medicure falling/rising?
2025-11-13 22:47:47As of 13-Nov, Poly Medicure Ltd's stock price is currently at Rs 1,971.20, reflecting a decrease of Rs 55.5 or 2.74%. The stock has been experiencing a downward trend, having lost 4.63% over the last two days. It touched an intraday low of Rs 1,952, indicating significant selling pressure. Despite a positive performance over the past week and month, with returns of 3.90% and 5.78% respectively, the stock has underperformed over the year with a decline of 25.36%. The company's low debt-to-equity ratio and high institutional holdings suggest some stability; however, flat results in recent earnings and a high price-to-book value indicate that the stock may be overvalued, contributing to its recent price decline. In the broader market context, while the Sensex has shown a positive return of 1.40% over the past week and 2.61% over the past month, Poly Medicure's performance has lagged significantly, particularl...
Read MoreWhy is Poly Medicure falling/rising?
2025-11-11 22:46:08As of 11-Nov, Poly Medicure Ltd's stock price is rising, currently at 2,066.95, reflecting a change of 205.65 or 11.05% upward. Today's performance indicates a trend reversal as the stock has gained after three consecutive days of decline, outperforming its sector by 2.2%. The stock reached an intraday high of Rs 2,093.95, demonstrating significant volatility with a wide trading range of Rs 242.25. Despite a year-to-date decline of 20.50% and a one-year drop of 24.15%, the stock has shown strong performance over the last three years, gaining 106.59%. The company benefits from a low debt-to-equity ratio and high institutional holdings, which may provide some support for its price movement. However, the recent flat results and underperformance relative to the broader market could be contributing to investor caution. In the broader market context, Poly Medicure's short-term return of 5.84% over the past week ...
Read More
Poly Medicure Soars 7.3%, Hits Intraday High of Rs 2004.95
2025-11-11 10:06:50Poly Medicure, a small-cap healthcare services company, experienced notable stock activity on November 11, 2025, with a significant intraday high. This performance follows a series of declines and contrasts with the broader market's downturn. The stock has shown resilience over the past five years, despite recent challenges.
Read MoreIs Poly Medicure technically bullish or bearish?
2025-11-11 08:17:30As of 10 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Poly Medicure is bearish with moderate strength. Key indicators driving this stance include the daily moving averages indicating a bearish trend, and both the weekly and monthly Bollinger Bands also confirming bearish conditions. The MACD shows a mildly bullish signal on the weekly chart but is mildly bearish on the monthly, indicating mixed signals across time frames. Additionally, the Dow Theory supports a mildly bearish outlook on both weekly and monthly bases. Overall, the bearish trend is reinforced by the recent price action, with a significant decline in stock performance compared to the Sensex over multiple time frames....
Read More
Poly Medicure Experiences Mixed Technical Trends Amidst Market Evaluation Revision
2025-11-11 08:07:24Poly Medicure, a small-cap healthcare services company, has seen its stock price decline recently, with notable fluctuations in trading. While facing challenges in short-term performance compared to the Sensex, the company has achieved substantial long-term growth, reflecting resilience over the past decade.
Read MoreWhy is Poly Medicure falling/rising?
2025-11-10 22:38:46As of 10-Nov, Poly Medicure Ltd's stock price is currently at Rs 1,862.10, reflecting a decrease of Rs 31.2 or 1.65%. The stock has been experiencing a downward trend, having lost value for the last three days, resulting in a total decline of 4.65% during this period. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Additionally, the stock is close to its 52-week low, just 2.12% away from Rs 1,822.65. The delivery volume has also decreased significantly, falling by 26.68% compared to the 5-day average, suggesting a decline in investor participation. In the broader market context, Poly Medicure's recent performance has been underwhelming compared to the benchmark Sensex, which has shown a slight decline of only 0.53% over the past week while the stock itself has dropped by 2.77%. Over the past month, the stock has decreased by 1.77%, contra...
Read MoreHow has been the historical performance of Poly Medicure?
2025-11-09 22:47:56Answer: The historical performance of Poly Medicure shows a consistent growth trajectory in net sales, with figures rising from 610.83 Cr in Mar'19 to 1,669.83 Cr in Mar'25. The total operating income has followed a similar upward trend, reaching 1,669.83 Cr in Mar'25, compared to 610.83 Cr in Mar'19. Operating profit has also increased significantly, with the operating profit (PBDIT) rising from 147.72 Cr in Mar'19 to 541.97 Cr in Mar'25. Profit before tax has shown a robust increase from 98.67 Cr in Mar'19 to 447.34 Cr in Mar'25, while profit after tax has grown from 64.00 Cr to 333.38 Cr over the same period. The company's earnings per share (EPS) have improved from 7.41 in Mar'19 to 33.41 in Mar'25, reflecting strong profitability growth. In terms of balance sheet metrics, total assets have surged from 767.32 Cr in Mar'20 to 3,192.13 Cr in Mar'25, indicating significant expansion. Shareholder's funds ...
Read MoreIntimation Of Investors/Analyst Virtual Calls
22-Nov-2025 | Source : BSEEnclosed
Intimation Of Investors/Analyst Virtual Call On 24Th November 2025
20-Nov-2025 | Source : BSEIntimation of Analysts/Investors Call
Intimation Of Investotrs/Analyst Virtual Call On 24Th November 2025
19-Nov-2025 | Source : BSEEnclosed
Corporate Actions
No Upcoming Board Meetings
Poly Medicure Ltd has declared 70% dividend, ex-date: 18 Sep 25
Poly Medicure Ltd has announced 5:10 stock split, ex-date: 02 Feb 15
Poly Medicure Ltd has announced 1:1 bonus issue, ex-date: 24 Mar 17
No Rights history available






